Duncan-Williams Places 'Buy' Rating on Vascular Solutions (VASC); "Aging of the Population" to Drive Increase in Demand/Volume
Tweet Send to a Friend
Earlier this morning, Duncan-Williams initiated coverage on Vascular Solutions (NASDAQ: VASC) with a Buy rating. Price target $10.50.
Some details ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Some details ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
